No annual revenue total was found in SNOWDRIFT PARENT CORPORATION's SEC filings.
Snowdrift Parent Corporation (CMMB) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$11.1 million. As of Dec 31, 2025 it held $7.6 million in cash and investments and $0 in total debt.
Revenue
—
Net income
$-8.99M
+35.5% vs prior year
Operating cash flow
$-11.13M
+27.7% vs prior year
Free cash flow
$-11.13M
+27.6% vs prior year
EPS
$0.02
-53.8% vs prior year
Dividend per share
None
Shares outstanding
575.38M
+52.6% vs prior year
Net cash
$7.56M
FY 2025
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMMB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534248
- Former names
- Anchiano Therapeutics Ltd. (until Mar 17, 2021); BioCancell Ltd. (until Nov 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$112.0M | -$103.0M | — | — | — |
| Net income | -$9.0M | -$13.9M | -$24.2M | -$27.6M | -$12.5M |
| Diluted EPS | $0.02 | $0.04 | $0.10 | $0.12 | — |
| Operating cash flow | -$11.1M | -$15.4M | -$23.6M | -$20.4M | -$12.4M |
| Free cash flow | -$11.1M | -$15.4M | -$23.6M | -$20.4M | -$12.6M |
| Total assets | $13.8M | $17.0M | $22.2M | $43.1M | $64.4M |
| Total liabilities | $1.5M | $3.4M | $5.2M | $6.8M | $2.9M |
| Stockholders' equity | $12.3M | $13.5M | $17.0M | $36.2M | $61.5M |
| Cash and investments | $7.6M | $6.1M | $9.3M | $13.5M | $15.2M |
| Total debt | $0 | $324,000 | $392,000 | $214,000 | $343,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 19, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 8, 2026 | Jul 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
All 366 Snowdrift Parent Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.